EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Indications for venom immunotherapy






Monograph on insect allergy (Ed. 2): 53-56

Indications for venom immunotherapy

Indications for initiation of immunotherapy against the venoms of stinging Hymenoptera are discussed.


Accession: 001615619



Related references

Sub-class of IgG anti-bee venom antibody produced during bee venom immunotherapy and its relationship to long-term protection from bee stings and following termination of venom immunotherapy. Clinical Allergy 16: 317-322, 1986

Subclass of immunoglobulin g anti bee venom antibody produced during bee venom immunotherapy and its relationship to long term protection from bee stings and following termination of venom immunotherapy. Clinical Allergy 16(4): 317-322, 1986

Indications for discontinuation of venom immunotherapy. Monograph on insect allergy (Ed. 2): 67-72, 1986

Venom allergy: indications for immunotherapy according to recent epidemiological data. Revue Francaise d' Allergologie et d' Immunologie Clinique 44(3): 270-275, 2004

Hymenoptera venom immunotherapy. I. Induction of T cell-mediated immunity by honeybee venom immunotherapy: relationships with specific antibody responses. Journal of Allergy and Clinical Immunology 83(3): 563-571, 1989

Rush venom immunotherapy in patients experiencing recurrent systemic reactions to conventional venom immunotherapy. Annals of Allergy, Asthma & Immunology 91(4): 405-410, 2003

Rush venom immunotherapy in patient with previous anaphylaxis during venom immunotherapy. Journal of Allergy & Clinical Immunology 97(1 PART 3): 338, 1996

Successful immunotherapy with T-cell epitopes of bee venom phospholipase A-2 in patients with bee venom allergy. Journal of Allergy & Clinical Immunology 97(1 PART 3): 426, 1996

Predictive value of venom-specific IgE, IgG and IgG subclass antibodies in patients on immunotherapy with honey bee venom. Allergy 44(6): 412-418, 1989

Bee venom immunoglobulin for prophylaxis of anaphylactic reactions during bee venom immunotherapy (rush hyposensitization). Immunology and Allergy Practice 107: 15-19, 1986